학술논문
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
Document Type
Article
Author
Casali, P.G.; Le Cesne, A.; Velasco, A.P.; Kotasek, D.; Rutkowski, P.; Hohenberger, P.; Fumagalli, E.; Judson, I.R.; Italiano, A.; Gelderblom, H.; Penel, N.; Hartmann, J.T.; Duffaud, F.; Goldstein, D.; Martin-Broto, J.; Gronchi, A.; Wardelmann, E.; Marréaud, S.; Zalcberg, J.R.; Litière, S.; Blay, J.-Y.
Source
In Annals of Oncology April 2021 32(4):533-541
Subject
Language
ISSN
0923-7534